ACUR
Acura Pharmaceuticals
ACUR
ACUR
Delisted
ACUR was delisted on the 22nd of February, 2017.
22 hedge funds and large institutions have $10.2M invested in Acura Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Holders
22
Holding in Top 10
1
Calls
$17K
Puts
$13K
Top Buyers
| 1 | +$10K | |
| 2 | +$4.75K | |
| 3 | +$3.92K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$106 |
Top Sellers
| 1 | -$115K | |
| 2 | -$39.8K | |
| 3 | -$39.4K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$10.8K |
| 5 |
SIM
Spark Investment Management
New York
|
-$6.99K |